Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MJWDE
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
PD0721-DOX ADC
|
|||||
| Synonyms |
PD0721-DOX ADC
Click to Show/Hide
|
|||||
| Organization |
Guizhou Medical University, Guiyang, Guizhou, China.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
9.23
|
|||||
| Structure |
|
|||||
| Antibody Name |
PD0721
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor variant III (EGFRvIII)
|
Antigen Info | ||||
| Payload Name |
Doxorubicin
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 2-alpha (TOP2A)
|
Target Info | ||||
| Linker Name |
dextran T-10
|
Linker Info | ||||
| Conjugate Type |
Site asparaginate random conjugation.
|
|||||